Upgrading the Gleason Score in Extended Prostate Biopsy: Implications for Treatment Choice

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 353-356

  Moreira Leite, Katia Ramos ^a,b   Camara Lopes, Luiz H A ^b   Dall'Oglio, Marcos F ^a   Cury, Jose ^a   Antunes, Alberto A ^a   Sañudo, Adriana ^a   Srougi, Miguel ^a  

^a Medical School   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Gleason score; Prostate biopsy; Prostate cancer; Radical prostatectomy

Indexed keywords

DECISION MAKING; MULTIVARIANT ANALYSIS; ONCOLOGY; TUMORS;

GLEASON SCORE; MULTIVARIATE ANALYSES; PROSTATE BIOPSY; PROSTATE CANCER; RADICAL PROSTATECTOMY; SIDE EFFECTS; TUMOR VOLUMES;

BIOPSY;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER THERAPY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TUMOR BURDEN;

EID: 58149350289     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.039     Document Type: Article

References (16)

1. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228-1242
2. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529-534
3. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus adjuvant prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
4. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of RTOG 85-31. J Clin Oncol 15 (1997) 1013-1021
5. Bolla M., Gonsalex D., Warde P., et al. Improves survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
6. Sharifi N., Gulley J.L., and Dahut W.L. Androgen deprivation therapy for prostate cancer. JAMA 294 (2005) 238-244
7. Horwich A., Parker C.C., Huddart R.A., et al. Management of early prostate cancer. Ann Oncol 13 Suppl 4 (2002) 83-87
8. King C.R., McNeal J.E., Gill H., et al. Extended prostate biopsy scheme improves reliability of Gleason grading: Implications for radiotherapy patients. Int J Rad Oncol Biol Phys 59 (2004) 386-391
9. Mian B.M., Lehr D.J., Moore C.K., et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 67 (2006) 379-383
10. Divrik R.T., Eroglu A., Sahin A., et al. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol Oncol Semin Orig Invest 25 (2007) 376-382
11. Miyake H., Kurahashi T., Takenaka A., et al. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Urol Int 79 (2007) 302-306
12. Kassouf W., Nakanishi H., Ochiai A., et al. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies. J Urol 178 (2007) 111-114
13. Carlson G.D., Calvanese H.K., Kahane H., et al. Accuracy of biopsy Gleason scores from a large uropathology laboratory: Use of a diagnostic protocol to minimize observer variability. Urology 51 (1998) 525-529
14. Kulkarni G.S., Lockwood G., Evans A., et al. Clinical predictors of Gleason score upgrading-Implications for patients considering watchful waiting, active surveillance or brachytherapy. Cancer 109 (2007) 2432-2438
15. Mian B.M., Lehr D.J., Moore C.K., et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 67 (2006) 379-383
16. Cooperberg M.R., Lubeck D.P., Mehta S.S., et al. Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE). J Urol 170 (2003) S21-S27